Honey Therapy
The honey used in this study was a carbohydrate content of the Egyptian clover honey of 78,4 g/100 g pH 3,7 and 18,8 percent humidity. The honey content was 37.8 and 30.2 g percent respectively in fructose and glucose. Beginnering on October 3, 2002, all the medicines had been stopped and honey was taken empirically 2 gm / kg / day, taking the weight of 75 kg i.e. 150 gm (125 ml) of sweetheart daily. The daily dose of 50 ml (60 gm) of honey was dissolved into water and administered twice a day before meals. For sweetening purposes, the remaining 25 ml (30 gm) were used. Honey dissolution in water increases honey's anti-microbial properties, allows swallowing and dose adjustment. With 3 kcal per gm of sweetness, this daily dose of sweetness produced 450 kcal. This calorie was not removed from his food because he had no certain diet restrictions except food preservatives and add-ons, drinks and sweets.
High Impact List of Articles
-
Subcutaneous panniculitis-like T cell lymphoma in a patient with juvenile idiopathic arthritis treated with Abatacept
Stephen Boyle, Veena Dhillon, Angus Broom & John R Goodlad
Case Report: International Journal of Clinical Rheumatology
-
Subcutaneous panniculitis-like T cell lymphoma in a patient with juvenile idiopathic arthritis treated with Abatacept
Stephen Boyle, Veena Dhillon, Angus Broom & John R Goodlad
Case Report: International Journal of Clinical Rheumatology
-
Utilizing the METEOR initiative to improve rheumatoid arthritis patient care
KI Salomon-Escoto, R van den Berg, J Kay, D van der Heijde & on behalf of the Merit Foundation
Special Issue Article: International Journal of Clinical Rheumatology
-
Utilizing the METEOR initiative to improve rheumatoid arthritis patient care
KI Salomon-Escoto, R van den Berg, J Kay, D van der Heijde & on behalf of the Merit Foundation
Special Issue Article: International Journal of Clinical Rheumatology
-
Diagnosis and treatment of cutaneous leukocytoclastic vasculitis
CE Gota & LH Calabrese
Review Article: International Journal of Clinical Rheumatology
-
Diagnosis and treatment of cutaneous leukocytoclastic vasculitis
CE Gota & LH Calabrese
Review Article: International Journal of Clinical Rheumatology
-
Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents
MA Jeffries & AH Sawalha
Review Article: International Journal of Clinical Rheumatology
-
Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents
MA Jeffries & AH Sawalha
Review Article: International Journal of Clinical Rheumatology
-
Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?
Olivier Bruyere & Jean-Yves Reginster
Review Article: International Journal of Clinical Rheumatology
-
Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?
Olivier Bruyere & Jean-Yves Reginster
Review Article: International Journal of Clinical Rheumatology
Relevant Topics in Clinical